Giles Toogood
University of Oxford
Post-Graduate:Oxford, Cambridge and Adelaide, Australia
Professor in Hepatobiliary Surgery, St James’s University Hospital and University of Leeds
Spire Hospital Leeds
Nuffield Hospital Leeds
President Elect Association of Upper Gastrointestinal Surgeons 2016 onwards
Chairman Great Britain and Ireland Hepatopancreatobiliary Association, 2009-2012
Chairman of Association of Upper Gastrointestinal Surgeons Committee of Education and Training, 2012-2016
Intercollegiate Specialty Boards Examiner for General Surgery, 2008 - to present
General Surgery Specialty Training Committee of Yorkshire, 1999 - to present
Royal College of Surgeons of England Assessor for Consultant Advisory Committees, 2005 - to present
European and African Hepatopancreatobiliary Association Education Committee, 2008 - to present
European Union of Medical Specialists Examiner, 2009 - to present
Chief External Examiner for University of Oxford 2014 to present
Clinical research is focused on outcome data of liver, gallbladder and transplantation patients, whilst laboratory work is aimed at novel treatments for people with colorectal liver cancer.
Over the past twelve years he has co supervised eight postgraduate fellows working towards PhDs and MDs, looking at the action of COX2 inhibitors (non steroidal anti inflammatory drugs) on colorectal liver cancer cells and producing a potential vaccination for colorectal liver cancer.
Author of over 160 publications and co applicant for several research grants. His publications can be accessed by typing in Toogood G at www.ncbi.nlm.nih.gov/pubmed